This combination tablet is indicated to:

• Inhibit ovulation
• Inhibit sperm from entering the uterus by condensing uterine mucus
• Inhibit the fertilized egg from being accepted by the uterus by protecting the growth of the membrane inside the uterus
• Reduce the movement of sperm by minimizing the normal movement of the fallopian tube. So sperm die as it takes a long time to come into contact with the ovum

This combination tablet is suitable for:

• Women aged between 15-69 years (except smokers and those who use tobacco regularly)
• Women who want an effective, temporary contraceptive method
• Women who are suffering from anemia due to excessive blood loss during menstruation
• Women having an irregular menstruation cycle
• Breastfeeding mothers (if the child is more than 6 months old)

Each White (Hormone) Tablet contains Ethinylestradiol USP 0.03 mg & Levonorgestrel USP 0.15 mg. Each Brown color (Iron) Tablet contains Ferrous Fumarate BP 75 mg. 

This pill is an effective, temporary and short-term birth control management for women. This tablet contains two hormones, Levonorgestrel and Ethinyl Estradiol. Every single strip contains 28 tablets, of which 21 tablets contain hormone and 7 tablets contain iron. Combination oral contraceptives lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.

One should start taking this tablet from the first day of menstruation. It can be started any day within the first 5 days of menstruation. One tablet should be taken at the same time each day with food, but the best time is after dinner or before sleeping at night. Start your dose with one white tablet each day for 3 (three) weeks. After that, take one brown color tablet each day for 7 (seven) days. If menstruation starts while taking the brown color tablet, do not stop the medicine. If not pregnant is confirmed, then the dose can be started from any day of menstruation, but after menstruation, one must use a condom during sexual intercourse for the next 7 (seven) days. When the 7 (seven) brown tablets are finished, whether menstruation has started or not, start the dose from the beginning with the white tablet.

If you forget to take a tablet for a day, you should take the tablet as soon as you notice it, and take another tablet as the dose for the present day. If you forget to take the tablet for two consecutive days, then this contraceptive will not work. However, to maintain the date of the menstruation cycle, you should take two tablets at a time as soon as you notice it

With medicine: Drugs or herbal products that induce certain enzymes, including CYP3A4, may decrease the effectiveness of COCs or increase breakthrough bleeding. Counsel patients to use a back-up method or alternative method of contraception when enzyme inducers are used with COCs.

With food and others: It is recommended to avoid caffeine, dairy foods, and foods containing phytic acid while taking the drug.

Contraindicated in case of known hypersensitivity to any of the components of this product.

Common: Headache, nausea, mood changes including depression, vaginal infections, irregular vaginal bleeding, pain, and discomfort. Rare: Liver tumors, jaundice, high blood pressure, and gallbladder problems.

This pill is contraindicated during pregnancy. Discontinue this pill if pregnancy occurs. Combined hormonal contraceptives (CHCs) and/or their metabolites are present in human milk and in breast-fed infants. CHCs including this pill can reduce milk production in breastfeeding females.

• Thrombotic disorder and other vascular problems: Stop this pill if a thrombotic disorder occurs. Stop at least 4 weeks before through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery in women who are not breastfeeding.

• Liver disease: Discontinue this pill if jaundice occurs.

• High blood pressure: If used in women with well-controlled hypertension, monitor blood pressure and stop this pill if blood pressure rises significantly.

• Carbohydrate and lipid metabolic effects: Monitor prediabetic and diabetic women taking this pill. Consider an alternative contraceptive method for women with uncontrolled dyslipidemia.

• Headache: Evaluate significant change in headaches and discontinue this pill if indicated.

• Bleeding irregularities and amenorrhea: Evaluate irregular bleeding or amenorrhea.

Safety and efficacy of this pill have been established in women of reproductive age. Efficacy is expected to be the same in post-pubertal adolescents under the age of 18 years as for users 18 years and older. Use of this product before menarche is not indicated.

There have been no reports of serious illness effects from overdose of oral contraceptives, including ingestion by children. Overdosage may cause withdrawal bleeding in females and nausea.

Oral Contraceptive preparations

Store below 30°C, protected from light & moisture. Keep all medicines out of reach of children.